PTSD symptoms significantly reduced three months after starting treatment with cannabis-based medicines.
The Danish Medicines Agency has not identified any safety issues with the prescribed cannabis products included in the programme.
The findings have cast doubt over any potential expansion of the Medical Cannabis Access Programme (MCAP).
Via Business of Cannabis Australia and New Zealand are undergoing contrasting reforms in their medical cannabis regulations. New Zealand aims to lower product quality standards for...
Researchers at LVR University Hospital Essen in Germany have announced the results of a new study on the efficacy of medical cannabis in treating chronic depression....
The study is said to 'lay the foundations' for for further research to explore cannabis as a treatment for Long COVID symptoms.
The findings could pave the way for new treatments for appetite disorders experienced by cancer patients, anorexia and obesity.
Insiders suggest the move may be a political ploy to put pressure on the bill's opponents.
The HHS has released documents confirming its recommendation that cannabis be rescheduled as a lower risk drug.
Researchers found no short-term increase in health service use or frequency of psychotic disorders.
Medical cannabis associations have called for the approval requirement to be scrapped for all conditions.